Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease:

Safa Ahmadian, Don D Sin, Larry Lynd, Mark Harrison, Mohsen Sadatsafavi

14 October, 2022

NZ Respiratory Research Review Issue 204

Lifetime occupational exposures and chronic obstructive pulmonary disease risk in the UK Biobank cohort:

Sara De Matteis, Debbie Jarvis, Lucy Darnton, Dario Consonni, Hans Kromhout, Sally Hutchings, Steven S Sadhra, David Fishwick, Roel Vermeulen, Lesley Rushton, Paul Cullinan

16 September, 2022

NZ Respiratory Research Review Issue 204

CFTR variants are associated with chronic bronchitis in smokers:

Aabida Saferali, Dandi Qiao, Wonji Kim, Karen Raraigh, Hara Levy, Alejandro A. Diaz, Garry R. Cutting, Michael H. Cho, Craig P. Hersh on behalf of NHLBI TransOmics in Precision Medicine (TOPMed)

10 August, 2022

NZ Respiratory Research Review Issue 203

Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea:

Yogesh N. V. Reddy, MD, MSc; David M. Kaye, MBBS, PhD; M. Louis Handoko, MD, PhD; et al

13 July, 2022

NZ Respiratory Research Review Issue 202

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing:

Simon Couillard, Rahul Shrimanker, Samuel Lemaire-Paquette, Gareth M Hynes, Catherine Borg, Clare Connolly, Samantha Jane Thulborn, Angela Moran, Sarah Poole, Sophie Morgan, Timothy Powell, Ian Pavord, Timothy Hinks

8 July, 2022

NZ Respiratory Research Review Issue 200

Selexipag for the treatment of chronic thromboembolic pulmonary hypertension:

Takeshi Ogo, Hiroto Shimokawahara, Hideyuki Kinoshita, Seiichiro Sakao, Kohtaro Abe, Satoaki Matoba, Hirohiko Motoki, Noriaki Takama, Junya Ako, Yasuhiro Ikeda, Shuji Joho, Hisataka Maki, Takahiro Saeki, Teruyasu Sugano, Ichizo Tsujino, Koichiro Yoshioka, Naoki Shiota, Shinichi Tanaka, Chieko Yamamoto, Nobuhiro Tanabe, Koichiro Tatsumi, for the Study Group

7 July, 2022

NZ Respiratory Research Review Issue 202

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry:

Athénaïs Boucly, Jason Weatherald, Laurent Savale, Pascal de Groote, Vincent Cottin, Grégoire Prévot, Ari Chaouat, François Picard, Delphine Horeau-Langlard, Arnaud Bourdin, Etienne-Marie Jutant, Antoine Beurnier, Mitja Jevnikar, Xavier Jaïs, Gérald Simonneau, David Montani, Olivier Sitbon, Marc Humbert

30 June, 2022

NZ Respiratory Research Review Issue 202

‘Breathing Fire’: Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma:

Beyene et al.

16 June, 2022

NZ Respiratory Research Review Issue 200

Lung function trajectory in progressive fibrosing interstitial lung disease:

Justin M. Oldham, Cathryn T. Lee, Zhe Wu, Willis S. Bowman, Janelle Vu Pugashetti, Nam Dao, James Tonkin, Hasan Seede, Gabrielle Echt, Ayodeji Adegunsoye, Felix Chua, Toby M. Maher, Christine K. Garcia, Mary E. Strek, Chad A. Newton, Philip L. Molyneaux

16 June, 2022

NZ Respiratory Research Review Issue 201

When should palliative care be introduced for people with progressive fibrotic interstitial lung disease? A meta-ethnography of the experiences of people with end-stage interstitial lung disease and their family carers:

Evelyn Palmer, Emely Kavanagh, Shelina Visram, Anne-Marie Bourke, Ian Forrest and Catherine Exley

11 June, 2022

NZ Respiratory Research Review Issue 201